about
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapyVaccination against respiratory Pseudomonas aeruginosa infectionThe draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory diseasepH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic AgentsBiochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia InfectionsOxylipins produced by Pseudomonas aeruginosa promote biofilm formation and virulenceRelease of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosisMolecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune EvasionPseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin.Defining a mutational panel and predicting the prevalence of cystic fibrosis in omanRole of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patientsThe search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae.Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa.Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patientsFunctional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis.Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity.Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.Effects of Emulsion Composition on Pulmonary Tobramycin Delivery During Antibacterial Perfluorocarbon Ventilation.The Burkholderia cenocepacia OmpA-like protein BCAL2958: identification, characterization, and detection of anti-BCAL2958 antibodies in serum from B. cepacia complex-infected Cystic Fibrosis patients.Flow environment and matrix structure interact to determine spatial competition in Pseudomonas aeruginosa biofilms.Oxidized fatty acids as inter-kingdom signaling molecules.New perspectives in the management of Pseudomonas aeruginosa infections.Exploring the Anti-Burkholderia cepacia Complex Activity of Essential Oils: A Preliminary Analysis.Achromobacter respiratory infections.SPX-101 is a Novel ENaC-targeted Therapeutic for Cystic Fibrosis that Restores Mucus Transport.Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use AntibioticsExposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens.Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients.Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo
P2860
Q26738321-CF30FCE8-1217-465A-A056-386AAC93ABF0Q26771869-6307C7AF-484B-425A-9016-49F8FEF60D81Q26824014-22109E90-2C20-491F-95E3-B9CEFEC7DB28Q27564108-3F33C3CD-7BC3-4351-8703-975D1B04EB3BQ28070241-630A304B-F982-4152-A68C-A1A451BFD324Q28554573-01C571E9-2F14-49C4-976F-3F503F6557E7Q30831867-85FDEF22-4C16-4E39-AFE2-BDB504BF8F5BQ33654992-91541F1B-D5ED-4A35-8EC6-D31A68A6D4E2Q33785116-F6AEE34B-9291-4474-B1AC-6191AB6EB8EFQ33819308-1FA3C2C8-88B0-4DE9-B804-B1A92E044A92Q33820108-1206BF80-3313-4A16-A741-C6E226281F36Q33901237-104686CA-1B6C-4FE0-859F-91FA55F756E7Q33982915-055E151C-E62F-4E71-9FAB-FDBE852B48D4Q34529950-93E008E3-0AA0-406F-AA15-0346BC8B7179Q34537770-DCF0E6B1-B3EA-4CBB-9502-F589FB017B79Q35023371-B92442C6-63C2-439E-B27B-F86D3BF1B78DQ35060335-FC0FC82C-4DB3-4321-A0FD-A6E67FAF6C8AQ35106279-B5B031AE-7A8D-462C-99F0-CCB1A36661ACQ35151823-0EC473C5-9FF8-4D36-B013-A955DFB48F01Q35541366-BB34A387-F1CF-473C-A320-760AA662C8D2Q35761876-BDB717F9-17BD-432E-9D4B-5AC75F4265ECQ35922452-E4426B23-8B15-44F7-A411-6F8AF7D8FF10Q36109402-0BF51335-3BBA-4850-9347-AEF1E47B9CCEQ36199673-F643D4C0-7E38-460D-9DDB-D73BDA68D9B7Q36893415-F61FD5E7-7EAD-4B75-84DF-F2CCA1EA041AQ36971632-A4850A39-C193-4CC3-ABB7-C23645778604Q37026632-CE64D226-F298-4844-B02A-CC3F7A2F94E7Q37616727-A7C74B63-8E65-4CF8-9FF7-7DEDED7B7998Q38180557-B61DAC47-7498-4D62-B1C9-3772212D7CD2Q38243221-7606D4C6-8A01-4681-A3B3-D999A90C714BQ38256032-B7E9E036-5688-4036-B2A9-CD7D3B5D8E79Q38364314-4B7B0CC5-F91D-4AC3-A459-E163749C713DQ38798339-F242F96A-176B-4AB0-A608-7EB1D4C433CDQ38992886-5DCF7991-AF75-4FCD-BCAC-406F882D8F8CQ39074001-5EFCB73C-1D1A-4312-8ACA-99ECA0795380Q39260742-AABCA804-FF50-405A-B059-D08DC16A1952Q40054770-F997B08F-1AC1-45F4-9556-3928ED08962CQ40356203-9E69765A-1336-4F81-9885-689AF24115B5Q40440920-009A1A33-53A7-482E-9B99-495B2428EBCDQ40556314-A62109EB-C6D3-4207-9E89-094F1A617236
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Respiratory bacterial infections in cystic fibrosis.
@en
type
label
Respiratory bacterial infections in cystic fibrosis.
@en
prefLabel
Respiratory bacterial infections in cystic fibrosis.
@en
P1476
Respiratory bacterial infections in cystic fibrosis.
@en
P2093
Christine R Hansen
P304
P356
10.1097/MCP.0B013E32835F1AFC
P577
2013-05-01T00:00:00Z